Search FUNI
Hypha Labs, Inc.
OTC Markets OTCQB · CIK 1502966
Last close0
Daily change+0.00 (4.65%)
10 Years gain-97.86%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
FUNI · STANDARD
SIC 8734 · Services-Testing Laboratories · Fiscal year end 0930
Fundamental
24.2Momentum
n/aAcceleration
n/aConfidence
70.0Annual Revenue13
Quarterly Revenue42
Annual CFO16
Balance SheetMissing
RankingLimited
Score Breakdown
Growth7.2 / 25
Quality15.8 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 15.6849 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM8.51%OK
Revenue CAGR 3Y1.89%OK
Gross Margin38.99%OK
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 30, 2025 | n/a | $0.00 | -$3.00M | -$379,975.00 | -$412,941.00 | n/a | n/a | n/a | n/a | 135.15M |
| 2025 FY Sep 30, 2024 | n/a | $0.00 | -$1.83M | -$1.03M | -$1.06M | n/a | n/a | n/a | n/a | 101.35M |
| 2024 FY Sep 30, 2023 | n/a | $0.00 | -$437,388.00 | $112,525.00 | n/a | n/a | n/a | n/a | n/a | 83.93M |
| 2023 FY Sep 30, 2022 | n/a | $0.00 | -$1.15M | -$184,786.00 | n/a | n/a | n/a | n/a | n/a | 74.17M |
| 2022 FY Sep 30, 2022 | $2.70M | $1.07M | n/a | n/a | n/a | 39.48% | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.71M | sum latest 4 fiscal quarters Revenue | OK | 0001493152-23-004973, 0001493152-22-013814 |
| Revenue Growth TTM | 8.51% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-23-004973, 0001493152-22-013814 |
| Revenue CAGR 3Y | 1.89% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-23-001551 |
| Revenue CAGR 5Y | 7.3% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-23-001551 |
| Gross Profit CAGR 3Y | 8.27% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-23-001551 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 38.99% | Gross Profit / Revenue | OK | 0001493152-23-004973, 0001493152-22-013814 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | derived |
| Gross Margin Delta 1Y | +15.68 pp | GrossMargin_current - GrossMargin_prior_year | OK | 0001493152-23-004973, 0001493152-22-013814 |
| Gross Margin Delta 3Y | +10.8 pp | GrossMargin_current - GrossMargin_3Y_ago | OK | 0001493152-23-004973, 0001493152-22-013814 |